We thank this reviewer for their comments and recognition that DNL343 provides a promising opportunity as therapy for neurodegenerative ailments. While our scientific studies share some similarities to Wong et al., eLifeBiomarkers starting to be significant for approval of amyotrophic lateral sclerosis therapies, claims GlobalData“NASH is really